The role of nicorandil in the treatment of myocardial ischaemia.

Expert Opin Pharmacother

Department of Cardiothoracic Surgery, Morriston Regional Cardiac Centre, Morriston Hospital, Swansea, Wales, UK.

Published: May 2001

Nicorandil is an anti-anginal agent that has been used in the United Kingdom for over 6 years and is becoming increasingly popular. It induces coronary and peripheral vasodilatation via a dualistic mode of action, mediated by the opening of potassium-ATP channels (K(ATP)) and its nitrate effect by stimulation of adenyl cyclase, with an increase in cGMP levels. Comparison to nitrates and other anti-anginal agents have shown it to be of equal efficacy in relieving ischaemic symptoms. Recent evidence suggests a role for nicorandil as a myocardial preconditioning agent but this may be limited by systemic vasodilatation. There is ongoing research into its role in improving the long-term outcome of patients with ischaemic heart disease (IHD). It has been shown to be of proven efficacy in the treatment of IHD and further research will clarify other uses of this agent.

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2.5.845DOI Listing

Publication Analysis

Top Keywords

role nicorandil
8
nicorandil treatment
4
treatment myocardial
4
myocardial ischaemia
4
ischaemia nicorandil
4
nicorandil anti-anginal
4
anti-anginal agent
4
agent united
4
united kingdom
4
kingdom years
4

Similar Publications

Nicorandil restores endothelial cell Kir6.2 expression to alleviate neuropathic pain in mice after chronic constriction injury.

Int Immunopharmacol

December 2024

Orthopedic Microsurgical Reconstruction Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, China. Electronic address:

The clinical management of neuropathic pain (NP) remains a significant challenge, as current pharmacological treatments do not fully meet clinical needs. Nicorandil, a potassium ATP channel agonist widely used in cardiovascular medicine, has recently been shown to have significant potential for analgesia. This study aimed to investigate the effects and mechanisms of nicorandil in a chronic constriction injury (CCI) mouse model.

View Article and Find Full Text PDF

Unraveling the Plausible Role of Potassium Channel Openers in Alzheimer's Disease.

Cent Nerv Syst Agents Med Chem

August 2024

Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Sector 125, Noida, 201301, India.

View Article and Find Full Text PDF

Background: Occupational and environmental exposure to chromium compounds such as potassium dichromate (PDC) (KCrO) has emerged as a potential aetiologic cause for renal disease through apoptotic, and inflammatory reactions. The known potent antioxidants such as nicorandil (NIC) and/or pentoxifylline (PTX) were studied for their possible nephroprotective effect in PDC-treated rats.

Methods: Forty male Wistar rats were divided into five groups; control, PDC group, NIC+PDC, PTX+PDC group, and combination+PDC group.

View Article and Find Full Text PDF
Article Synopsis
  • * In a rat model, nicorandil showed promising results by reducing damage indicators and exhibiting antioxidant and anti-inflammatory effects on lung tissue.
  • * The study revealed that nicorandil alters specific molecular pathways related to inflammation and cell stress, making it a compelling candidate for more extensive clinical trials to confirm its efficacy in lung injury prevention.
View Article and Find Full Text PDF

Nicorandil is a dual mechanism anti-anginal agent that acts as a nitric oxide (NO) donor and a potassium (K) channel opener. Recent studies have evaluated the effect of nicorandil on ischemic stroke. Neurons have a low tolerance to hypoxia and therefore the brain tissue is significantly vulnerable to ischemia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!